AWH 0.99 (-33.56%)
US04537Y1091Medical Diagnostics & ResearchDiagnostics & Research

Aspira Womens Health (AWH) Competitor Comparison

We are evaluating the key criteria listed to compare Aspira Womens Health (AWH) against its competitors in the Diagnostics & Research industry.

Performance 5 years - AWH ranking 52 / 58

These are the competitors of Aspira Womens Health in the industry Diagnostics & Research ranked by performance 5 years
1. Medpace Holdings MEDP
541.91
2. RadNet RDNT
336.77
3. Natera NTRA
297.69
4. Fulgent Genetics FLGT
219.54
5. DexCom DXCM
209.19
6. Lantheus Holdings LNTH
190.17
7. DarioHealth DRIO
158.7
8. Meridian Bioscience VIVO
118.46
9. Icon ICLR
105.99
10. Danaher DHR
98.5
11. Thermo Fisher Scientific TMO
89.02
12. IDEXX Laboratories IDXX
79.11
13. Agilent Technologies A
76.95
14. Twist Bioscience TWST
74.38
15. Mettler-Toledo MTD
67.32
16. Co-Diagnostics CODX
50.97
17. PerkinElmer PKI
48.44
18. Charles River Laboratories CRL
47.09
19. Laboratory Corp of America Holdings LH
38.44
20. Quest Diagnostics DGX
36.2
21. Waters WAT
35.6
22. IQVIA Holdings IQV
34.83
23. Trinity Biotech TRIB
29.09
24. Ortho Clinical Diagnostics Holdings OCDX
13.74
25. Heska HSKA
12.14
26. Qiagen QGEN
1.53
27. Myriad Genetics MYGN
-8.53
28. Syneos Health SYNH
-16.98
29. Inotiv NOTV
-20.57
30. Olink Holding OLK
-28.51
31. NeoGenomics NEO
-35.64
32. Anixa Biosciences ANIX
-35.94
33. Neogen NEOG
-48.76
34. Sotera Health SHC
-56.04
35. CareDx CDNA
-56.98
36. National Research NRC
-58.51
37. Sera Prognostics SERA
-60.56
38. Bioventus BVS
-61.92
39. Exact Sciences EXAS
-63.59
40. Guardant Health GH
-65.95
41. Enzo Biochem ENZ
-69.55
42. Illumina ILMN
-70.78
43. bioAffinity Technologies BIAF
-74.29
44. Psychemedics PMD
-74.82
45. MaxCyte MXCT
-76.93
46. Pacific Biosciences of California PACB
-77.13
47. MDxHealth MDXH
-80.33
48. Neuronetics STIM
-83.56
49. Interpace Biosciences IDXG
-84.03
50. Global Cord Blood CO
-86.47
51. Biodesix BDSX
-88.74
52. Aspira Womens Health AWH
-88.84
53. Exagen XGN
-89.17
54. Precipio PRPO
-90.32
55. Prenetics Global PRE
-95.05
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.1
58. Personalis PSNL
-95.83

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.